Exor Buys Back 240,450 Shares Under Tranche
Exor N.V. completed a second tranche of its share buyback program, purchasing shares on Euronext Amsterdam and CBOE DXE.
Updated on Nov. 16, 2026 in Corporate Finance

Exor N.V. completed purchases of 240,450 ordinary shares under its second buyback tranche between 9 and 13 November 2026, on Euronext Amsterdam and CBOE DXE. The company has bought 740,070 shares under the tranche so far, investing approximately €53 million.
Why it matters
The buyback is part of a program of up to €125 million announced on 26 October 2026, and the growing treasury holdings reflect how the company is deploying capital against its share base. Treasury shares now stand at 3.64% of ordinary issued capital, which affects the share count investors hold a stake in.
Exor's disclosure reports 240,450 shares bought in the latest period, with average prices reported per share excluding fees, and 7,559,542 shares held in treasury as of 16 November 2026. The filing does not indicate how much of the €125 million authorization remains available or the timing of further purchases.
The players
Exor N.V.
Exor N.V. is a Dutch holding company that controls a diversified portfolio of industrial, financial and publishing businesses.
The details
Exor N.V. executed the purchases on Euronext Amsterdam, where total consideration was about €8.93 million, and on CBOE DXE, where total consideration was about €8.88 million. The company reported daily average prices per share excluding fees in euros.
Timeline
26 October 2026: Exor announces a buyback program of up to €125 million.
9 to 13 November 2026: Second tranche share purchases are executed on both exchanges.
16 November 2026: Treasury holdings are reported at 7,559,542 shares.
Market Dynamics
Exor's staged repurchases operate within the EU Market Abuse Regulation safe-harbour framework for buyback programs, which permits issuers to repurchase shares under defined conditions. The second tranche follows the program's October 2026 announcement and executes purchases across Euronext Amsterdam and CBOE DXE.
For holders of Exor shares, the buyback reduces the number of shares outstanding that are available to trade, which can affect per-share metrics for the remaining free float. The disclosure carries no direct effect on consumer prices or household budgets.
The takeaway
Buyback disclosures report cumulative totals, so tracking the running count of treasury shares across filings shows how much of an authorization has been used. Investors can compare reported average prices against the market to judge how the company is deploying capital.
Further reading
For more on how companies handle capital returns, see Corporate Finance.
Source note: This article includes information reported by The Manila times.



